1. Cobo G, Lindholm B, Stenvinkel P. Chronic inflammation in end-stage renal disease and dialysis. Nephrol Dial Transplant. 2018; 33 (suppl_3): iii35-iii40.

  2. Gupta R, Woo K, Jeniann AY, editors. Epidemiology of end-stage kidney disease. Semin Vasc Surg. 2021; 34 (1): 71-78.

  3. Wetmore JB, Johansen KL. Demographics of the End-Stage Renal Disease Patient. Handbook of Dialysis Therapy. Amsterdam: Elsevier; 2023. p. 3-15.

  4. Low S, Liew A, editors. Peritoneal dialysis fluids. Semin Dial; 2024: Wiley Online Library.

  5. Namdar A, Naghizadeh MM, Namdar F, et al. Health-related Quality of life in Patients on Hemodialysis Compared to Peritoneal Dialysis: A cross-sec¬tional Study. JABS. 2023; 13 (3): 196-207.

  6. Bello AK, Okpechi IG, Osman MA, et al. Epidemiology of peritoneal dialysis outcomes. Nat Rev Nephrol. 2022; 18 (12): 779-793.

  7. Yang L, Li J, Wei W, et al. Blood Pressure Variability and the Progression of Chronic Kidney Disease: A Systematic Review and Meta-Analysis. J Gen Intern Med. 2023; 38 (5):1272-1281.

  8. Tang M, Batty JA, Lin C, et al. Pulmonary hypertension, mortality, and cardiovascular disease in CKD and ESRD patients: A systematic review and meta-analysis. Am J Kidney Dis. 2018; 72 (1): 75-83.

  9. Shang W, Li Y, Ren Y, et al. Prevalence of pulmonary hypertension in patients with chronic kidney disease without dialysis: A meta-analysis. Int Urol Nephrol. 2018; 50: 1497-1504.

  10. Motedayen M, Sarokhani D, Ghiasi B, et al. Prevalence of hypertension in renal diseases in Iran: Systematic review and meta-analysis. Int J Prev Med. 2019; 10: 124.

  11. Dai S, Chen Y, Shang D, et al. Association of Ambulatory Blood Pressure with All-Cause Mortality and Cardiovascular Outcomes in Peritoneal Dialysis Patients. Kidney Blood Press Res. 2020; 45 (6): 890-899.

  12. Qiu Y, Ye H, Fan L, et al. Serum sodium modifies the association of systolic blood pressure with mortality in peritoneal dialysis patients. Kidney Blood Press Res. 2020; 45 (6): 916-925.

  13. Tajeu GS, Booth III JN, Colantonio LD, et al. Incident cardiovascular disease among adults with blood pressure <140/90 mm Hg. Circulation. 2017; 136 (9): 798-812.

  14. Mills KT, Obst KM, Shen W, et al. Comparative effectiveness of implementation strategies for blood pressure control in hypertensive patients: A system¬atic review and meta-analysis. Ann Intern Med. 2018; 168 (2): 110-120.

  15. Nguyen B, Bui QTH, Tran PQ. Survival Rates in Elderly Patients on Continuous Ambulatory Peritoneal Dialysis. Int J Nephrol Renovas Dis. 2023: 131-41.

  16. Yang J, Wan J, Feng L, et al. Machine learning algorithms for the prediction of adverse prognosis in patients undergoing peritoneal dialysis. BMC Med Inform Decis Mak. 2024; 24 (1): 8.

  17. Ott C, Schmieder RE. Diagnosis and treatment of arterial hypertension 2021. Kidney Int. 2022; 101 (1): 36-46.

  18. Schneider MP, Hilgers KF, Schmid M, et al. Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study. PLoS One. 2018; 13 (8): e0202604.

  19. Hougaard P. Analysis of multivariate survival data. Berlin: Springer; 2000.

  20. Najafi I, Alatab S, Atabak S, et al. Seventeen years’ experience of peritoneal dialysis in Iran: First official report of the Iranian peritoneal dialysis registry. Perit Dial Int. 2014; 34 (6): 636-642.

  21. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018; 71 (6): 1269-1324.

  22. Hosseini M, Yaseri M, Asady H, et al. Prevalence of high blood pressure in Iranian adults based on the 2017 ACC/AHA guideline. Med J Islam Repub Iran. 2019; 33: 26.

  23. Mohammadi S, Hassanipour S, Delam H, et al. Prevalence of hypertension in Iran: An updated systematic review and meta-analysis of community-based studies. Caspian J Intern Med. 2023; 14 (4): 607.

  24. Pugh D, Gallacher PJ, Dhaun N. Management of hypertension in chronic kidney disease. Drugs. 2019; 79 (4): 365-379.

  25. Yang J, Liu F, Wang B, et al. Blood pressure states transition inference based on multi-state markov model. IEEE J Biomed Health Inform. 2020; 25 (1): 237-246.

  26. Wang Y, Ma Z, Xu C, et al. Prediction of transfer among multiple states of blood pressure based on Markov model: An 18-year cohort study. J hyper¬tens. 2018; 36 (7): 1506-1513.

  27. Hall JE, Mouton AJ, da Silva AA, et al. Obesity, kidney dysfunction, and inflammation: Interactions in hypertension. Cardiovasc Res. 2021; 117 (8): 1859-1876.

  28. Parvanova A, Reseghetti E, Abbate M, et al. Mechanisms and treatment of obesity-related hypertension—Part 1: Mechanisms. Clin Kidney J. 2024; 17 (1): sfad282.

  29. Manolis AA, Manolis TA, Melita H, et al. Low serum albumin: a neglected predictor in patients with cardiovascular disease. Eur J Intern Med. 2022; 102: 24-39.

  30. Bansal S. Peritoneal Membrane Dysfunction. Complications in Dialysis: A Clinical Guide. 2023: 245-52.

  31. Healthcare Engineering JO. Retracted: Low Serum Albumin Is Associated with Poor Prognosis in Patients Receiving Peritoneal Dialysis Treatment. J Healthc Eng. 2023; 2023: 9891861.

  32. Alves FC, Sun J, Qureshi AR, et al. The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease. PloS one. 2018; 13 (1): e0190410.

  33. Kang SC, Park KS, Chang TI, et al. Sleep apnea is associated with residual kidney function and mortality in patients with peritoneal dialysis: Prospective cohort study. Semin Dial. 2022; 35 (2): 146-153.

  34. Cheng S-Y, Yang L-M, Sun Z-S, et al. Risk factors for mortality within 6 mo in patients with diabetes undergoing urgent-start peritoneal dialysis: A mul¬ticenter retrospective cohort study. World J Diabetes. 2022; 13 (4): 376.

  35. O’Sullivan ED, Hughes J, Ferenbach DA. Renal aging: Causes and consequences. J Am Soc Nephrol: JASN. 2017; 28 (2): 407.

  36. Fang Y, Gong AY, Haller ST, et al. The ageing kidney: Molecular mechanisms and clinical implications. Ageing Res Rev. 2020; 63: 101151.

  37. Afghahi H, Nasic S, Peters B, et al. Long-term glycemic variability and the risk of mortality in diabetic patients receiving peritoneal dialysis. PloS one. 2022; 17 (1): e0262880.

  38. Ceriello A, Monnier L, Owens D. Glycaemic variability in diabetes: Clinical and therapeutic implications. Lancet Diabetes Endocrinol. 2019; 7 (3): 221-230.

  39. Wu N, Shen H, Liu H, et al. Acute blood glucose fluctuation enhances rat aorta endothelial cell apoptosis, oxidative stress and pro-inflammatory cy¬tokine expression in vivo. Cardiovasc Diabetol. 2016; 15 (1): 1-13.